TSHA
Taysha Gene Therapies, Inc.
NASDAQHealthcareBiotechnologyUS
USD5.55
-0.14 (-2.46%)
Rating:C
Company Profile
CEO
Sean Nolan
IPO Date
2020-09-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$5.68
Prev. Close
$5.69
Day Low
$5.43
Day High
$5.69
52W Low
$2.25
52W High
$7.30
Market Cap
$1.39B
Volume
1.53M